Related to Product and Service Firms Challenged by Uncertain NIH Funding, Polarization of Sequencing

• GenomeQuest Awards $120K in Grants to Support NGS-Based Diagnostics
  
• Poll Results Point to Personal Sequencing Platforms Entering the Clinic This Year
  
• Roche Outlines $5.7B Bid to Buy Illumina for $44.5 Per Share in Cash
  
• Illumina Institutes Poison Pill to Ward Off Roche’s $5.7B Purchase Proposal
  
• Illumina Shuns Roche’s $5.7 Bid, While Roche Prepares for the Long Haul
  
• DNAnexus Allies with Geisinger, UCSF to Augment Clinical Sequencing
  
• Complete Genomics Sets Up Genomic Discovery Software Partners Program
  
• Rutgers University Cell and DNA Repository Taps PerkinElmer NGS Sample Prep Solutions
  
• New York Genome Center Launches Its First Project with Feinstein Institute
  
• Arrowhead Research Taps Axolabs for siRNA Services
  
• LaserGen Wins Grant for Next-Gen Sequencing Test for Wound Infection Pathogens
  
• Chronix Opens South Dakota Sequencing Lab for Cancer and Rare Disease Services
  
• Presidential Panel Expected to Sort Out Ethics of Clinical Sequencing, According to GEN Poll
  
• Preamplified Nanopore Senses Briefest Signals Generated by High-Speed DNA
  
• Biological Nanopore Sequencing Platform Reads DNA at Single-Nucleotide Resolution
  
• Asuragen to Receive $6.8M from the Cancer Prevention and Research Institute of Texas
  
• New York Genome Center Gets $3M from Sloan Foundation
  
• GE Snags Sequencing Services Firm SeqWright
  
• Iris Pharma, RxGen Partner on Integrated Ophthalmology Research Services
  
• OncoMed Taps Genomic Health to Identify Predictive Biomarkers for Anticancer Antibodies